1. Home
  2. TPST vs GYRO Comparison

TPST vs GYRO Comparison

Compare TPST & GYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • GYRO
  • Stock Information
  • Founded
  • TPST 2011
  • GYRO 1946
  • Country
  • TPST United States
  • GYRO United States
  • Employees
  • TPST N/A
  • GYRO N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • GYRO Building operators
  • Sector
  • TPST Health Care
  • GYRO Real Estate
  • Exchange
  • TPST Nasdaq
  • GYRO Nasdaq
  • Market Cap
  • TPST 27.2M
  • GYRO 23.1M
  • IPO Year
  • TPST N/A
  • GYRO N/A
  • Fundamental
  • Price
  • TPST $0.89
  • GYRO $9.97
  • Analyst Decision
  • TPST Strong Buy
  • GYRO
  • Analyst Count
  • TPST 4
  • GYRO 0
  • Target Price
  • TPST $20.00
  • GYRO N/A
  • AVG Volume (30 Days)
  • TPST 3.3M
  • GYRO 1.6K
  • Earning Date
  • TPST 11-12-2024
  • GYRO 01-01-0001
  • Dividend Yield
  • TPST N/A
  • GYRO N/A
  • EPS Growth
  • TPST N/A
  • GYRO N/A
  • EPS
  • TPST N/A
  • GYRO N/A
  • Revenue
  • TPST N/A
  • GYRO $2,738,019.00
  • Revenue This Year
  • TPST N/A
  • GYRO N/A
  • Revenue Next Year
  • TPST N/A
  • GYRO N/A
  • P/E Ratio
  • TPST N/A
  • GYRO N/A
  • Revenue Growth
  • TPST N/A
  • GYRO N/A
  • 52 Week Low
  • TPST $0.83
  • GYRO $7.65
  • 52 Week High
  • TPST $6.00
  • GYRO $11.96
  • Technical
  • Relative Strength Index (RSI)
  • TPST 34.45
  • GYRO 50.75
  • Support Level
  • TPST $0.94
  • GYRO $10.15
  • Resistance Level
  • TPST $1.16
  • GYRO $10.69
  • Average True Range (ATR)
  • TPST 0.10
  • GYRO 0.15
  • MACD
  • TPST 0.00
  • GYRO -0.14
  • Stochastic Oscillator
  • TPST 15.50
  • GYRO 55.49

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About GYRO Gyrodyne LLC

Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.

Share on Social Networks: